-

FAT SHAREHOLDER ALERT: Robbins LLP Reminds Shareholders of Class Action Against FAT Brands Inc. (FAT, FATBB, FATBP, FATBW)

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired FAT Brands Inc. (NASDAQ: FAT) securities between December 4, 2017 and February 18, 2022, for violations of the Securities Exchange Act of 1934. Fat Brands purports to be a franchising company that acquires, develops, and markets quick-service, fast casual and casual dining restaurants.

If you would like more information about FAT Brands Inc.'s misconduct, click here.

What is this Case About: FAT Brands Inc. (FAT) CEO Accused of Engaging in Fraudulent Tax Scheme and Obtaining Sham Loans

According to the complaint, on February 19, 2022, the Los Angeles Times published an article entitled "Family behind Fatburger under investigation for alleged fraud, money laundering, records show," which revealed investigations into the Company's CEO, Andrew Wiederhorn, and his COO son in connection with the Company. The article revealed that the CEO had "devised and executed a fraudulent scheme" to avoid paying taxes and received "millions of dollars in sham loans" through his companies. The article also noted "an alleged scheme to route millions of dollars of company money through American Express charges to a PayPal account bearing [Thayer Wiederhorn's] name." This scheme generated $250,000 in fees to PayPal "for no legitimate corporate purpose."

This is not the first time Andrew Wiederhorn has encountered legal trouble. In 2004, he pleaded guilty to charges of paying an illegal gratuity to an associate and filing a false tax return. He spent 15 months in prison and paid a $2 million fine.

On February 22, 2022, the Company filed with the SEC a Form 8-K announcing that the FBI had opened investigations in December 2021. On this news, FAT Brands stock fell.

Next Steps: If you acquired shares of FAT Brands Inc. (FAT) between December 4, 2017 and February 18, 2022, you have until May 17, 2022, to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against FAT Brands Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Urges GOSS Stockholders to Contact the Firm for Information About the Class Action Against Gossamer Bio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease.For more information, submit a form, email att...

Robbins LLP Urges IBRX Stockholders to Contact the Firm for Information About the Class Action Against ImmunityBio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? January 19, 2026 – March 25, 202...

Robbins LLP Reminds ALDX Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Case Against Aldeyra Therapeutics, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities between November 3, 2023 and March 16, 2026. Defendant Aldeyra describes itself as a “biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated diseases.” Pertinent to this action is reproxalap, which is a novel reactive aldehyde species (RASP) inhib...
Back to Newsroom